Bevespi Aerosphere approved by the US FDA for patients with COPD

22 April 2016 - AstraZeneca announced that the US FDA has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol for ...

Read more →